Actos Bladder Cancer Risk Halts Sales in Europe
Actos Sales Suspended in Germany, France
Due to research which suggests an Actos bladder cancer link, France and Germany have suspended sales of the diabetes medication. The health regulators in these countries decided to halt the use of Actos after receiving results of a French study, which examined patients taking Actos between 2006 and 2009 and revealed an increased risk of bladder cancer among Actos users. While the FDA has not taken as strong of an action in light of this possible Actos bladder cancer risk, legal recourse may still be available to users of the drug who were diagnosed with cancerous tumors of the bladder.
Diagnosed with bladder cancer after taking the diabetes drug Actos, ActoPlus Met, ActoPlus Met XR or Duetact? Find out if you can file a claim to recover financial compensation by completing our our no cost, no risk case evaluation form.
Actos Bladder Cancer FDA Warning
The FDA continues to monitor an ongoing, ten-year study of Actos, but has refrained from issuing an Actos recall or suspending sales of the drug. In June 2011, however, it released an Actos bladder cancer FDA warning alerting the public to a possible risk of bladder cancer in patients being treated with the drug for a year or longer. The Actos bladder cancer FDA safety announcement advised doctors to counsel their patients to report blood in the urine, pain during urination, urinary urgency, or back or abdominal pain, as these may be signs of bladder cancer. Furthermore, the agency warned doctors against using Actos in patients with active bladder cancer, and to prescribe it with caution to those with a history of the disease.
Lawyers for Actos Bladder Cancer
In its Actos bladder cancer FDA warning, the agency announced that due to the bladder cancer risk, the labels of Actos and other pioglitazone-containing medications will be updated to reflect this possible side effect. However, Actos lawsuits are being filed, alleging that the manufacturer of the drug did not take adequate steps to warn patients and doctors of this risk prior to this label update. If you or a loved one has been diagnosed with bladder cancer after taking Actos, ActoPlus Met, ActoPlus Met XR or Duetact, you may have legal recourse to seek compensation for damages for the manufacturer's alleged failure to warn. To find out if you qualify for an Actos bladder cancer lawsuit, complete our free case review form today.